Friday, August 23, 2013

Hyaluronan degrading silica nanoparticles for skin cancer therapy




Nanoscale , 2013, Advance Article

DOI: 10.1039/C3NR02787B, Paper

P. Scodeller, P. N. Catalano, N. Salguero, H. Duran, A. Wolosiuk, G. J. A. A. Soler-Illia

Hacking the way into tumors. We report the first nanoformulation of Hyaluronidase (Hyal) self-assembled onto a polymer-modified silica surface. This enzyme-nanoparticle composite presents an enhanced adjuvant effect for the antitumoral action of carboplatin on melanoma via the degradation of the extracellular matrix (ECM). This concept could prove useful in future therapies.

To cite this article before page numbers are assigned, use the DOI form of citation above.

The content of this RSS Feed (c) The Royal Society of Chemistry





Click for full article

No comments:

Post a Comment